Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Sekisui OSOM Flu SARS-CoV-2 Combo Control Kit

Catalog No. 22321144 Shop All SEKISUI Diagnostics Products
Change view
Click to view available options
Detectable Analytes:
SARS-CoV-2, Influenza A and B
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Detectable Analytes
22-321-144 SARS-CoV-2, Influenza A and B
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. 22-321-144 Supplier Sekisui Supplier No. 1079
Only null left
Add to Cart
Edge
Add to Cart
This item is not returnable. View return policy

OSOM Flu SARS-CoV-2 Combo Control Kit is intended for use in external quality control with the OSOM Flu SARS-CoV-2 Combo Antigen Test Kit. For Emergency Use Authorization Only.

  • Contains:
    • 5 - Flu A / Flu B / SARS-CoV-2 Positive Control Swab (packaged with a desiccant tablet) coated with non-infectious recombinant influenza A, influenza B, and SARS-CoV-2 containing 0.05% sodium azide
    • 5 Flu A / Flu B / SARS-CoV-2 Negative Control Swabs (packaged with a desiccant tablet) coated with nonviable Group C Streptococci containing 0.09% sodium azide
  • Intended for use in external quality control with the OSOM Flu SARS-CoV-2 Combo Antigen Test Kit
  • For Emergency Use Authorization Only
TRUSTED_SUSTAINABILITY

Specifications

Detectable Analytes SARS-CoV-2, Influenza A and B
Format Kit
For Use With (Equipment) For use in external quality control with the OSOM Flu SARS-CoV-2 Combo Antigen Test Kit
Sample Type Swab
Type Positive and Negative Lyophilized swab
Form Lyophilized

In the USA, this product has not been FDA cleared or approved, but has been authorized by FDA under an Emergency Use Authorization. This product has been authorized only for the detection of proteins from SARS-CoV-2, influenza A and influenza B, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. §360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.